Open-Label Study of I-131-CLR1404 in Subjects With Recurrent Glioma

NCT01778088 · clinicaltrials.gov ↗
PHASE2
Phase
WITHDRAWN
Status
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Cellectar Biosciences, Inc.